Nigama Ekkad, PhD

Topic: Astral – a Cutting-Edge Platform for Multi-Omics Applications 2024 Global R&D 100 Winner This year, a cutting-edge plaform for multi-omics applications was recognized as one of TOP100 most innovative technologies in the global prestigious R&D 100 Awards. The R&D 100 Awards is the only science and technology awards competition that recognizes new products and technologies for their technological significance. The Orbitrap Astral platform is an advanced tool designed for comprehensive multi-omics analyses, encompassing genomics, proteomics, metabolomics, and lipidomics. Utilizing state-of-the-art mass spectrometry with the highly accurate Orbitrap mass analyzer, it offers exceptional resolution and sensitivity. This platform enables detailed molecular profiling and quantification, facilitating simultaneous multi-omics workflows. By streamlining data acquisition and analysis, the Orbitrap Astral platform accelerates research in biomarker discovery, disease mechanisms, and therapeutic development, setting a new standard for multi-omics investigations.